By: Kacal (Senate Sponsor - Schwertner) H.B. No. 2425
(In the Senate - Received from the House April 15, 2019;
April 16, 2019, read first time and referred to Committee on Health &
Human Services; May 8, 2019, reported favorably by the following
vote: Yeas 9, Nays 0; May 8, 2019, sent to printer.)
Click here to see the committee vote
A BILL TO BE ENTITLED
AN ACT
relating to the authority of physicians to delegate to certain
pharmacists the implementation and modification of a patient's drug
therapy.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 157.101, Occupations Code, is amended by
amending Subsection (b-1) and adding Subsection (g) to read as
follows:
(b-1) A delegation under Subsection (b) may include the
implementation or modification of a patient's drug therapy under a
protocol, including the authority to sign a prescription drug order
for dangerous drugs, if:
(1) the delegation follows a diagnosis, initial
patient assessment, and drug therapy order by the physician;
(2) the pharmacist practices in a federally qualified
health center, a hospital, a hospital-based clinic, or an academic
health care institution;
(3) the federally qualified health center, hospital,
hospital-based clinic, or academic health care institution in which
the pharmacist practices has bylaws and a medical staff policy that
permit a physician to delegate to a pharmacist the management of a
patient's drug therapy;
(4) the pharmacist provides the name, address, and
telephone number of the pharmacist and of the delegating physician
on each prescription signed by the pharmacist; and
(5) the pharmacist provides a copy of the protocol to
the Texas State Board of Pharmacy.
(g) In this section, "federally qualified health center"
has the meaning assigned by Section 531.02192, Government Code.
SECTION 2. This Act takes effect September 1, 2019.
* * * * *